Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors

Transfusion

Volumn 39, Issue 10, 1999, Pages 1136-1140

  McCullough, Jeffrey ^a   Clay, M ^a   Herr, G ^a   Smith, J ^a   Stroncek, D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE PAIN; DRUG TOLERABILITY; FATIGUE; FEMALE; GRANULOCYTE TRANSFUSION; GROWTH STIMULATION; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NEUTROPHIL; PERIPHERAL CIRCULATION;

ADOLESCENT; ADULT; BLOOD CELL COUNT; BLOOD DONORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTES; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0032827538     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39101136.x     Document Type: Article

References (29)

1. McCullough J. Leukapheresis and granulocyte transfusion. CRC Crit Rev Clin Lab Sci 1979;10:275-327.
2. Huestis DW, White RF, Price MJ, Inman M. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor. Transfusion 1975;15:559-64.
3. Sussman LN, Colli W, Pichetshote C. Harvesting of granulocytes using a hydroxyethyl starch solution. Transfusion 1975;15:461-5.
4. Lowenthal RM, Park DS. The use of dextran as an adjunct to granulocyte collection with the continuous-flow blood cell separator. Transfusion 1975;15:23-7.
5. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood 1974;44:571-81.
6. Aisner J, Schiffer CA, Wiernik PH. Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis. Br J Haematol 1978;38:121-9.
7. Mishler JM, Higby DJ, Rhomberg W, et al. Hydroxyethyl starch and dexamethasone as an adjunct to leukocyte separation with the IBM blood cell separator. Transfusion 1974;14:352-6.
8. McCredie KB, Freireich EJ, Hester JP, Vallejos C. Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch. Transfusion 1974;14:357-64.
9. Winton EF, Vogler WR. Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with the continuous-flow centrifugal blood cell separator. Blood 1978;52:249-53.
10. Higby DI, Mishler JM, Rhomberg W, et al. The effect of a single or double dose of dexamethasone on granulocyte collection with the continuous flow centrifuge. Vox Sang 1975;28:243-8.
11. Graw RG Jr, Herzig GP, Eisel RJ, Perry S. Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion 1971;11:94-101.
12. Loftus TJ, White RF, Huestis DW. Leukapheresis: increasing the granulocyte yield with the Fenwal CS-3000. J Clin Apheresis 1983;1:109-14.
13. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993;81:1675-8.
14. Anderlini P, Przepiorka D, Champlin R, Korbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-25.
15. Weite K, Gabrilove J, Bronchud MH, et al. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996;88:1907-29.
16. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte-colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
17. Liles WC, Huang JE, Llewellyn C, et al. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997;37:182-7.
18. Price TH, Bowden RA, Boeckh M, et al. Neutrophil collection from community apheresis donors after granulocyte colony-stimulating factor and dexamethasone stimulation: feasibility and efficacy (abstract). Blood 1997;90(Suppl 1):137b.
19. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte colony-stimulating factor. Blood 1993;81:2877-71.
20. Dale DC, Liles WC, Llewellyn C, et al. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion 1998;38:713-21.
21. Hester J, Dignani MC, Anaissie EJ, et al. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 1995;10:188-93.
22. Strauss RG. Neutrophil (granulocyte) transfusions in the new millennium (editorial). Transfusion 1998;38:710-2.
23. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996;36:601-10.
24. Stroncek DF, Clay ME, Smith J, et al. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996;36:596-600.
25. Stroncek DF, Clay ME, Herr G, et al. The kinetics of G-CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997;7:19-24.
26. Stroncek DF, Clay ME, Jaszcz W, et al. Collection of two peripheral blood stem cell concentrates from healthy donors. Transfus Med 1999;9:37-50.
27. Stroncek DF, Clay ME, Herr G, et al. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 1997;37:304-30.
28. Klein HG, ed. Standards for blood banks and transfusion services. 16th ed. Bethesda: American Association of Blood Banks, 1994.
29. Leitman SF, Oblitas JM. Optimization of granulocytapheresis mobilization regimens using granulocyte colony stimulating factor (G-CSF) and dexamethasone (DEXA) (abstract). Transfusion 1997;37(Suppl):67S.